Trimi vs Henry Meds: GLP-1 Comparison 2026

Trimi and Henry Meds both offer GLP-1 medications through telehealth platforms, but they differ in pricing structure, medication selection, and clinical support. This guide breaks down how the two programs compare so you can make an informed decision about your weight loss treatment in 2026.

Quick Comparison Overview

Note: Pricing and offerings change frequently. Visit each company's website for the most current information.

Medications Offered

Trimi

Trimi offers compounded semaglutide at $99/month, compounded tirzepatide at $125/month, and retatrutide. Having all three major GLP-1 receptor agonists available means providers can match patients to the most appropriate medication based on health profile, weight loss goals, and individual response. If one medication causes side effects or produces a plateau, switching to another is straightforward within the same program.

Henry Meds

Henry Meds offers compounded semaglutide and compounded tirzepatide through their telehealth platform. They have built a streamlined onboarding process and offer pharmacy-compounded medications from 503B facilities. Henry Meds has positioned itself as a provider with transparent pricing and straightforward access to GLP-1 medications.

Where Henry Meds excels: They have a relatively clear onboarding process and have established themselves as a recognizable name in the compounded GLP-1 space. Their platform is easy to navigate and they have invested in patient education materials.

Pricing Breakdown

This is one of the most significant differences between the two platforms:

• Trimi semaglutide: $99/month, flat rate regardless of dose
• Trimi tirzepatide: $125/month, flat rate regardless of dose
• Henry Meds: Pricing typically varies by dose tier, meaning costs increase as you titrate to higher doses

The difference in pricing models matters significantly over time. Most patients titrate to higher doses over months of treatment. With dose-dependent pricing, your monthly cost at a maintenance dose can be substantially higher than your starting price. Trimi's flat-rate approach means your cost stays the same whether you are on a starting dose or a higher maintenance dose.

12-Month Cost Projection

For a patient on compounded semaglutide who titrates from a starting dose to a maintenance dose over 12 months:

• Trimi: $99 x 12 = $1,188 total
• Henry Meds: Total varies based on dose-dependent pricing structure, potentially $2,400-4,200+ depending on final maintenance dose

These are estimates based on publicly available pricing. Always confirm current pricing directly with each provider.

Clinical Support and Provider Access

Trimi's Approach

Trimi was built specifically for GLP-1 weight loss treatment. The clinical model emphasizes dedicated providers who specialize in GLP-1 therapy, ongoing support with regular check-ins and dose adjustments, responsive communication for questions about side effects and lifestyle, and personalized titration plans tailored to individual tolerance and response.

Henry Meds' Approach

Henry Meds provides telehealth consultations with licensed providers who review patient intake forms, prescribe medications, and offer follow-up care. Their model focuses on making GLP-1 access straightforward and removing barriers to treatment.

Honest assessment: Both platforms connect patients with licensed healthcare providers. The depth and frequency of clinical interaction varies, and your experience with either platform depends partly on the specific provider assigned to you and how proactively you engage with the program.

Medication Selection Flexibility

One area where Trimi has a clear advantage is medication breadth. With semaglutide, tirzepatide, and retatrutide all available, Trimi providers can offer patients the option to switch medications if needed. This matters because:

• Some patients respond better to tirzepatide (dual GIP/GLP-1 agonist) than semaglutide (GLP-1 only)
• Side effect profiles differ between medications, and switching can resolve persistent issues
• Retatrutide, the triple agonist (GLP-1/GIP/glucagon), represents the next generation of weight loss medications
• Having all options under one provider means continuity of care during any transition

Who Each Program Is Best For

Choose Trimi If:

• You want the lowest flat-rate pricing for compounded GLP-1 medications
• Access to semaglutide, tirzepatide, and retatrutide matters to you
• You want dedicated provider support focused specifically on GLP-1 therapy
• You prefer predictable monthly costs that do not increase with dose titration

Choose Henry Meds If:

• You are already familiar with their platform and have an established relationship
• Their specific onboarding process or provider style appeals to you
• You have had positive experiences with their customer service
• Their current promotional pricing makes them cost-competitive for your situation

What We Admire About Henry Meds

Henry Meds has contributed to making GLP-1 medications more accessible through telehealth. They have helped normalize the idea that effective weight loss treatment should not require expensive in-person visits, and their marketing has been effective at reaching people who might not otherwise have known about compounded GLP-1 options. Competition in this space benefits patients by driving down prices and improving service quality.

Getting Started

If you are comparing GLP-1 programs, we encourage you to evaluate total cost at your expected maintenance dose, the range of medications available, the depth of clinical support, and the flexibility to switch medications if needed.

To learn more about Trimi, visit our treatment options page. Compounded semaglutide starts at $99/month and compounded tirzepatide at $125/month, with no dose-dependent price increases. Our team is happy to answer questions about our program.

Frequently Asked Questions

Is Trimi cheaper than Henry Meds?

Trimi's flat-rate pricing of $99/month for semaglutide and $125/month for tirzepatide is generally lower than Henry Meds' dose-dependent pricing, especially at higher maintenance doses. However, pricing changes frequently, so verify current rates with both providers before making a decision.

Does Henry Meds offer retatrutide?

As of early 2026, Henry Meds primarily offers compounded semaglutide and tirzepatide. Trimi offers all three major GLP-1 medications including retatrutide, providing broader medication selection for patients who may benefit from the triple agonist approach.

Can I switch from Henry Meds to Trimi?

Yes. Switching between telehealth GLP-1 programs is straightforward. A Trimi provider will review your treatment history, current dose, and response, then continue or adjust your plan accordingly. There is no medical barrier to transferring care between licensed providers.

Are both Trimi and Henry Meds legitimate?

Both platforms connect patients with licensed healthcare providers and source medications from FDA-registered 503B compounding pharmacies. Look for licensed prescribers, transparent pricing, and ongoing clinical support as markers of a legitimate GLP-1 telehealth program.

Which program has better clinical support?

Trimi was built specifically around GLP-1 weight management with dedicated providers who specialize in this area. Henry Meds also provides clinical support through their telehealth platform. The best program for you depends on how much personalized guidance you want and how proactively you engage with your provider team.